发明公开
- 专利标题： Alphavirus vectors for RSV and PIV vaccines
- 专利标题（中）： 甲型肝炎病毒感染RSV-PIV-Impfstoffe
-
申请号： EP14160481.9申请日： 2005-05-20
-
公开(公告)号： EP2811027A1公开(公告)日： 2014-12-10
- 发明人: Perri, Silvia , Polo, John , Uematsu, Yasushi , Greer, Catherine
- 申请人： Novartis Vaccines and Diagnostics, Inc.
- 申请人地址： 4560 Horton Street Emeryville, CA 94608-2916 US
- 专利权人： Novartis Vaccines and Diagnostics, Inc.
- 当前专利权人： Novartis Vaccines and Diagnostics, Inc.
- 当前专利权人地址： 4560 Horton Street Emeryville, CA 94608-2916 US
- 代理机构： Carpmaels & Ransford LLP
- 优先权： US573433P 20040521; US643737P 20050112
- 主分类号： C12N15/86
- IPC分类号： C12N15/86 ; A61K39/145 ; A61K39/155 ; A61K39/215 ; A61K39/12 ; A61K39/02 ; A61K39/00 ; A61K39/295
摘要：
Described herein are compositions and methods for stimulating an immune response to one or more proteins derived from one or more respiratory pathogens. In particular, the invention relates to alphavirus replicons, alphavirus vector constructs, alphavirus replicon particles expressing one or more antigens derived from one or more respiratory pathogens as well as to method of making and using these immunogenic compositions.
信息查询
IPC分类:
